Access cutting-edge cytomegalovirus infection treatment through this clinical trial at a research site in Omaha. Study-provided care at no cost to qualified participants.
Access cytomegalovirus infection specialists in Omaha at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cytomegalovirus infection treatment provided free
The main aim of this study is to find out the safety, tolerability and pharmacokinetics (PK) of maribavir for the treatment of CMV infection in children and teenagers after HSCT or SOT and to identify the optimal dose of maribavir using a 200 milligrams (mg) tablet formulation or powder for oral suspension. The participants will be treated with maribavir for 8 weeks. Participants need to visit their doctor during 12-week follow-up period.
Sponsor: Takeda
Check if you qualify for this cytomegalovirus infection clinical trial in Omaha, NE
If you're searching for cytomegalovirus infection treatment options in Omaha, NE, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Omaha research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cytomegalovirus infection specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.